Latest Insider Transactions at Willis Towers Watson PLC (WTW)
This section provides a real-time view of insider transactions for Willis Towers Watson PLC (WTW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WILLIS TOWERS WATSON PLC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WILLIS TOWERS WATSON PLC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 20
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
1,681
+2.29%
|
-
|
|
Apr 20
2025
|
Lucy Clarke President of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
1,422
+7.5%
|
-
|
|
Apr 15
2025
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.22%
|
-
|
|
Apr 15
2025
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140
+0.16%
|
-
|
|
Apr 15
2025
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.12%
|
-
|
|
Apr 15
2025
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.59%
|
-
|
|
Apr 15
2025
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.15%
|
-
|
|
Apr 15
2025
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.04%
|
-
|
|
Apr 15
2025
|
Lucy Clarke President of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.23%
|
-
|
|
Apr 15
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.03%
|
-
|
|
Apr 15
2025
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.09%
|
-
|
|
Apr 15
2025
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.14%
|
-
|
|
Apr 15
2025
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.14%
|
-
|
|
Apr 01
2025
|
Andrew Jay Krasner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,791
-67.55%
|
$1,277,567
$337.95 P/Share
|
|
Apr 01
2025
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
22
+0.19%
|
-
|
|
Apr 01
2025
|
Kristy D Banas Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,760
-18.63%
|
$593,120
$337.95 P/Share
|
|
Apr 01
2025
|
Kristy D Banas Chief Human Resources Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
9
+0.1%
|
-
|
|
Apr 01
2025
|
Matthew Furman General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,944
-7.86%
|
$992,128
$337.95 P/Share
|
|
Apr 01
2025
|
Matthew Furman General Counsel |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
12
+0.03%
|
-
|
|
Apr 01
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
2,866
-3.94%
|
$965,842
$337.95 P/Share
|
|
Apr 01
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
15
+0.02%
|
-
|
|
Apr 01
2025
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,421
-20.07%
|
$7,555,877
$337.95 P/Share
|
|
Apr 01
2025
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
96
+0.09%
|
-
|
|
Apr 01
2025
|
Imran Ahmed Qureshi Head of North America |
SELL
Payment of exercise price or tax liability
|
Direct |
2,548
-26.4%
|
$858,676
$337.95 P/Share
|
|
Apr 01
2025
|
Imran Ahmed Qureshi Head of North America |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
13
+0.13%
|
-
|
|
Apr 01
2025
|
Anne Pullum Head of Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
2,702
-13.79%
|
$910,574
$337.95 P/Share
|
|
Apr 01
2025
|
Anne Pullum Head of Europe |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
15
+0.08%
|
-
|
|
Apr 01
2025
|
Alexis Faber Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,716
-18.71%
|
$578,292
$337.95 P/Share
|
|
Apr 01
2025
|
Alexis Faber Chief Operating Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
9
+0.1%
|
-
|
|
Apr 01
2025
|
Joseph Stephen Kurpis PAO and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-17.45%
|
$79,869
$337.95 P/Share
|
|
Apr 01
2025
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1
+0.07%
|
-
|
|
Apr 01
2025
|
Pamela Thomson Hall Head of International |
SELL
Payment of exercise price or tax liability
|
Direct |
748
-12.93%
|
$252,076
$337.95 P/Share
|
|
Apr 01
2025
|
Pamela Thomson Hall Head of International |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
5
+0.09%
|
-
|
|
Mar 03
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,616
-2.17%
|
$546,208
$338.74 P/Share
|
|
Feb 28
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
3,384
-4.35%
|
$1,133,640
$335.77 P/Share
|
|
Feb 27
2025
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,349
-1.19%
|
$447,868
$332.82 P/Share
|
|
Feb 25
2025
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
5,362
+21.5%
|
-
|
|
Feb 25
2025
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,235
+25.53%
|
-
|
|
Feb 25
2025
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,550
+23.94%
|
-
|
|
Feb 25
2025
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,524
+27.78%
|
-
|
|
Feb 25
2025
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
489
+26.49%
|
-
|
|
Feb 25
2025
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
4,718
+32.86%
|
-
|
|
Feb 25
2025
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,339
+10.39%
|
-
|
|
Feb 25
2025
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
2,033
+26.03%
|
-
|
|
Feb 25
2025
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,845
+40.7%
|
-
|
|
Feb 25
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
5,576
+6.69%
|
-
|
|
Jan 15
2025
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.01%
|
-
|
|
Jan 15
2025
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.22%
|
-
|
|
Jan 15
2025
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.08%
|
-
|
|
Jan 15
2025
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|